Physician

Brandon Max Markus, D.O.

According to 2025 Medicare claims, Brandon Markus, D.O. (NPI: 1134440365) practices dermatology in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is DERMATOLOGY INSTITUTE AND SKIN CANCER CENTER LLC (NPI: 1891319422; TIN: 85-0782409) and primary practice location at 32163-2005.

Markus' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,716 traditional Medicare patients, billed 11,748 HCPCS/CPT codes, and received $845,173 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 917 prescription claims across 465 beneficiaries totaling $191,120 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 48 records totaling $1,067. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $36,857 and ending at $845,173. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $209,050 to $191,120. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	256	817	$36,857
2016	610	2,045	$117,422
2017	816	2,882	$548,903
2018	1,616	5,908	$1,280,611
2019	1,737	6,570	$1,484,800
2020	681	2,350	$422,219
2021	869	6,206	$545,314
2022	1,396	9,935	$768,363
2023	1,558	12,429	$947,646
2024	1,716	11,748	$845,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	198	420	$209,050
2016	162	364	$130,162
2017	203	316	$65,385
2018	343	523	$29,039
2019	263	412	$10,218
2020	104	163	$16,559
2021	254	467	$126,677
2022	404	837	$237,257
2023	450	1,034	$335,061
2024	465	917	$191,120

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	512	650	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,260	2,014	$61
11102	Biopsy of related skin growth, first growth	608	793	$60
17000	Destruction of precancer skin growth, 1 growth	902	1,325	$34
17003	Destruction of precancer skin growth, 2-14 growths	628	3,606	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	13	364	$48,652
Fluorouracil	Fluorouracil	45	1,278	$3,677
Clobetasol Propionate	Clobetasol Propionate	67	1,977	$3,151
Triamcinolone Acetonide	Triamcinolone Acetonide	277	8,451	$2,923
Metronidazole	Metronidazole	34	1,005	$1,965

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$1,067	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brandon Max Markus, D.O.?

Tedicare shows public-source Medicare data for Brandon Max Markus, D.O. (NPI 1134440365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brandon Max Markus, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brandon Max Markus, D.O.?

Brandon Max Markus, D.O. is linked to DERMATOLOGY INSTITUTE AND SKIN CANCER CENTER LLC (billing NPI 1891319422) in the available physician profile data.

Does Brandon Max Markus, D.O. have Open Payments data?

Brandon Max Markus, D.O. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.